戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 azine; the latter removed O acetyls from the O-specific polysaccharide.
2 tiveness of vaccines that exclusively target O-specific polysaccharide.
3                           The conjugate with O-specific polysaccharide activated by CDAP and bound to
4  cholera toxin B and A subunits, V. cholerae O-specific polysaccharide and lipopolysaccharide, toxin
5  generation of the serologic response to the O-specific polysaccharide and protection against virulen
6 ffects of K pneumoniae capsule production on O-specific polysaccharide antibody binding and O-specifi
7 strains, has the potential to interfere with O-specific polysaccharide antibody binding.
8 specific polysaccharide antibody binding and O-specific polysaccharide antibody-mediated complement d
9           We sought to determine whether the O-specific polysaccharide antigen is immunogenic in huma
10 t be necessary to include all subtypes in an O-specific polysaccharide-based vaccine.
11  serotype Ogawa, which comprises in part the O-specific polysaccharide component of the native LPS, a
12 lts showed that a vaccine of E. coli O157:H7 O-specific polysaccharide conjugated to recombinant exot
13  carbohydrates, including mannose-containing O-specific polysaccharides derived from bacterial lipopo
14 K pneumoniae bloodstream infection, and peak O-specific polysaccharide-IgG antibody responses in pati
15 dy, we compared plasma antibody responses to O-specific polysaccharide in a cohort of consecutively e
16 intact LPS containing various lengths of the O-specific polysaccharide in the range of 3 and 15 kDa w
17 tical (protective) level of serum IgG to the O-specific polysaccharide (O-SP) domain of Shigella lipo
18  hypothesis that serum IgG antibodies to the O-specific polysaccharide (O-SP) domains of the LPS of t
19                          The surface-exposed O-specific polysaccharide (O-SP) of the lipopolysacchari
20      Salmonella enterica serovar Paratyphi A O-specific polysaccharide (O-SP) was activated with 1-cy
21            In one study, the Shigella sonnei O-specific polysaccharide (O-SP)-protein conjugate showe
22  and a clinical trial with a Shigella sonnei O-specific polysaccharide (O-SP)-Pseudomonas aeruginosa
23 0-6, which are specific for Ogawa O-antigen (O-specific polysaccharide; O-SP) of V. cholerae O1, were
24 ing sequence forms the downstream end in the O-specific polysaccharide of both Vibrio cholerae O22 an
25 he case with Shigella, serum IgG against the O-specific polysaccharide of E. coli O157:H7 may confer
26 inst the surface polysaccharide antigen, the O-specific polysaccharide of lipopolysaccharide (LPS), m
27                                          The O-specific polysaccharide of S. paratyphi A is composed
28 a dimer of the basic repeating unit from the O-specific polysaccharide of Shigella flexneri 2a, a maj
29 c the terminal hexasaccharide epitope of the O-specific polysaccharide of Vibrio cholerae O1, serotyp
30  S flexneri 2a, 3a, and 6, and S sonnei, and O-specific polysaccharide (OSP) from S flexneri 2a and 3
31 as defined by a rise in serum V. cholerae O1 O-specific polysaccharide (OSP) immunoglobulin A (IgA) o
32                                       Common O-specific polysaccharide serotypes (O1, O2, O3, and O5)
33  from that of enteric organisms that express O-specific polysaccharide side chains.
34 nses among structurally related K pneumoniae O-specific polysaccharide subtypes and to assess the eff
35 he cross-reactivity observed between similar O-specific polysaccharide subtypes in patients with K pn
36     There was cross-reactivity among similar O-specific polysaccharide subtypes, including the O1v1 a
37 non-hyperencapsulated K pneumoniae inhibited O-specific polysaccharide-targeted antibody binding and
38 o assess the effect of capsule production on O-specific polysaccharide-targeted antibody binding and
39                                              O-specific polysaccharide was immunogenic in patients wi
40                                              O-specific polysaccharide was immunogenic in patients wi
41 enetically modified strains deficient in the O-specific polysaccharide, we isolated fractions of core
42  prepared by covalently binding E. coli O157 O-specific polysaccharide with Pseudomonas aeruginosa re